Lizhen Wang Selected Research

Glioblastoma (Glioblastoma Multiforme)

6/2019	Downregulation of miR‑186 promotes the proliferation and drug resistance of glioblastoma cells by targeting Twist1.
2/2016	Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lizhen Wang Research Topics

Disease

48	Neoplasms (Cancer) 01/2022 - 11/2008
12	Squamous Cell Carcinoma of Head and Neck 01/2020 - 03/2009
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2014
4	Carcinogenesis 01/2022 - 12/2013
4	Melanoma (Melanoma, Malignant) 01/2022 - 04/2016
4	Pain (Aches) 12/2021 - 03/2009
4	Parkinson Disease (Parkinson's Disease) 11/2021 - 12/2009
4	Infections 02/2021 - 01/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022 - 09/2021
3	Port-Wine Stain (Nevus Flammeus) 03/2022 - 06/2018
3	Body Weight (Weight, Body) 10/2021 - 10/2014
3	Inflammation (Inflammations) 10/2021 - 01/2020
3	Insulin Resistance 10/2020 - 05/2020
3	Wounds and Injuries (Trauma) 04/2020 - 01/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 03/2008
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2015
3	Knee Osteoarthritis 06/2014 - 03/2009
2	Ischemic Stroke 05/2022 - 10/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
2	Cardiotoxicity 01/2022 - 05/2020
2	Lung Neoplasms (Lung Cancer) 11/2021 - 05/2013
2	Osteoarthritis 10/2021 - 03/2017
2	Root Resorption 09/2021 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 09/2020 - 05/2020
2	Type 2 Diabetes Mellitus (MODY) 09/2020 - 01/2020
2	Foreign-Body Reaction 06/2020 - 01/2019
2	Hearing Loss (Hearing Impairment) 01/2020 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 10/2019 - 04/2019
2	Glioma (Gliomas) 06/2019 - 02/2016
2	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 02/2016
2	Leukemia 01/2019 - 01/2014
2	Pleomorphic Adenoma 01/2018 - 03/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 03/2017
2	Low Back Pain (Lumbago) 01/2017 - 11/2014
2	Iron Overload 12/2016 - 01/2016
2	Rupture 07/2015 - 01/2015
2	Insulinoma 01/2015 - 09/2014

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 01/2022 - 03/2008
11	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2009
9	Biomarkers (Surrogate Marker)IBA 11/2021 - 02/2010
7	Pharmaceutical PreparationsIBA 10/2020 - 08/2010
6	ElementsIBA 05/2022 - 04/2013
6	Biological ProductsIBA 01/2022 - 11/2013
6	Phosphotransferases (Kinase)IBA 11/2021 - 12/2009
6	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 02/2021 - 09/2014
5	LigandsIBA 01/2022 - 01/2015
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 09/2014
3	Melanins (Melanin)IBA 01/2022 - 01/2016
3	BerberineIBA 11/2021 - 01/2020
3	PolyphenolsIBA 10/2021 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2018
3	Insulin (Novolin)FDA Link 10/2020 - 01/2018
3	Blood Glucose (Blood Sugar)IBA 09/2020 - 01/2018
3	Retinaldehyde (Retinal)IBA 04/2020 - 04/2013
3	Indicators and Reagents (Reagents)IBA 01/2020 - 12/2014
3	FSH Receptors (FSH Receptor)IBA 03/2016 - 08/2014
2	AcidsIBA 01/2022 - 04/2019
2	Poloxamer (Poloxamer 407)IBA 10/2021 - 01/2018
2	Hormones (Hormone)IBA 06/2021 - 12/2014
2	CytokinesIBA 02/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 10/2020 - 06/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2020 - 01/2020
2	Epidermal Growth Factor (EGF)IBA 06/2020 - 12/2019
2	Caspase 9IBA 05/2020 - 01/2020
2	Caspase 3 (Caspase-3)IBA 05/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2020
2	Temozolomide (Temodar)FDA LinkGeneric 06/2019 - 02/2016
2	Exenatide (Byetta)FDA Link 01/2019 - 01/2015
2	Capsules (Microcapsules)IBA 01/2019 - 01/2015
2	CateninsIBA 10/2018 - 01/2015
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 03/2017
2	IronIBA 12/2016 - 01/2016
2	Angiogenesis InhibitorsIBA 02/2016 - 09/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 12/2014
2	GelatinasesIBA 12/2015 - 01/2015
2	Matrix Metalloproteinase InhibitorsIBA 12/2015 - 01/2015
2	EnzymesIBA 12/2015 - 03/2008
2	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 01/2015
2	Parathyroid Hormone (Parathormone)IBA 11/2015 - 12/2014
2	Bombesin Receptors (Bombesin Receptor)IBA 09/2014 - 06/2014
1	phytobacteriomycin (PBM)IBA 04/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Durapatite (Hydroxylapatite)IBA 01/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2022
1	Aprotinin (Trasylol)FDA Link 01/2022

Therapy/Procedure

20	Therapeutics 10/2020 - 05/2013
6	Radiotherapy 01/2022 - 01/2011
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2021 - 01/2013
5	Acupuncture Therapy 10/2020 - 01/2013
4	Lasers (Laser) 12/2021 - 07/2006
3	Precision Medicine 06/2020 - 01/2017
3	Acupuncture Points (Acupuncture Point) 08/2019 - 07/2006
2	Photochemotherapy (Photodynamic Therapy) 03/2022 - 12/2021
2	Splints (Splint) 10/2017 - 07/2015
2	Traction 01/2017 - 11/2014
1	Thrombectomy 05/2022
1	Stents 05/2022
1	Chemoradiotherapy 04/2022